Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.

Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.

Item
http://www.wikidata.org/entity/Q46487009
Pharmacological treatment options for mast cell activation diseaseProstaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.Determination of plasma heparin level improves identification of systemic mast cell activation diseaseDefinitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalImmunology and clinical manifestations of non-clonal mast cell activation syndromeMastocytosis: update on pharmacotherapy and future directions.Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disordersSpectrum of mast cell activation disorders.Current treatment options in patients with mastocytosis: status in 2015 and future perspectives.Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.Mast Cells and Anaphylaxis.Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis.Characterization and modulation of canine mast cell derived eicosanoids.Presentation of untreated systemic mastocytosis as recurrent, pulseless-electrical-activity cardiac arrests resistant to cardiac pacemaker.Effect of oral eicosapentaenoic acid on epidermal Langerhans cell numbers and PGD2 production in UVR-exposed human skin: a randomised controlled study.Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: The results of a double-blind, placebo-controlled challenge study
P2860

Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.

Item
http://www.wikidata.org/entity/Q46487009
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Prevention of mast cell activa ...... e of excessive prostaglandin D
@nl
Prevention of mast cell activa ...... prostaglandin D(2) production.
@en
type
label
Prevention of mast cell activa ...... e of excessive prostaglandin D
@nl
Prevention of mast cell activa ...... prostaglandin D(2) production.
@en
prefLabel
Prevention of mast cell activa ...... e of excessive prostaglandin D
@nl
Prevention of mast cell activa ...... prostaglandin D(2) production.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Prevention of mast cell activa ...... prostaglandin D(2) production.
@en
P2093
P304
P31
P356
P433
P478
P577
P698
P921